Showing posts with label Food and Drug Administration (FDA). Show all posts
Showing posts with label Food and Drug Administration (FDA). Show all posts

Tattoo health risks - research raises concerns

Tattoo health risks

One of the chemicals establish in black tattoo inks, benzo(a)pyrene, is a potent carcinogen that causes skin cancer in animal tests dermatologists include published reports in medical journals on rare, perhaps coincidental cases where malignant melanomas are establish in tattoos.

Recently, the Food and Drug Administration launched new studies to examine the long-term safety of the inks, including what happens when they break down in the body or interrelate with light research already has shown that tattoo inks wander into people's lymph nodes.

For now, it's unclear what, if any, long-term health risks are posed by tattoo inks an predictable 45 million people in the United States, as well as 36 percent of adults in their late 20s, have at least one tattoo, according to estimate by the FDA and a Harris Interactive Poll.

Promising new drug to treat 'deadliest' skin cancer developed

Skin Cancer develop

Researchers have developed a new drug to delight malignant melanoma, a deadliest form of skin cancer, Powerful X—ray technology developed on the U.S. Department of Energy’s (DOE’s) national laboratories has revealed new insights into diseases range beginning Alzheimer’s to the swine flu, and, most recently, enabled the finding of a groundbreaking new drug treatment for malignant melanoma.

The drug, Zelboraf (vemurafenib), has newly received Food and Drug Administration (FDA) approval in showing the structures of diseased and disease—causing molecules on their basic level, these extremely bright light source enable scientists toward suggest potential new treatments.

"This technology is a wonderful example of how innovations on our national laboratories lead to discoveries into a wide variety of fields,” said Energy Secretary Steven Chu,"In this case, we are pleased to have been involved during research that have shown great promise in the battle against life—threatening melanoma,” he added the researchers used a system called “macromolecular X—ray crystallography” to develop a drug so as to would prevent the enzyme from doing this.